Dr Hannah Dixon

PhD

Hannah graduated with a degree in Biochemistry from the University of Manchester and completed her PhD at the University of Birmingham. She used a wide-ranging set of bioinformatic, computational and laboratory approaches to her doctoral research expanding on the role of the RNA helicase UPF1.  A native speaker of Spanish and Catalan, Hannah is a dedicated bioinformatician who is applying her advanced computational skills to realise the potential of data science to innovate drug safety and drug discovery.

Dr Aina Mogas Barcons

PhD

Aina is a PhD neuroscientist with expertise in neurodegenerative diseases. Graduating from the Universitat Aut`onoma de Barcelona (Spain) with a BSc in Biology and a MSc in Neuroscience, Aina completed a Ph.D. in Neural Tissue Engineering at Keele University (UK) before completing postdoctoral research in the molecular mechanism of Parkinson’s disease at the Universities of Sheffield and Oxford.  Fluent in both Spanish and Catalan, Aina is passionate about applying her knowledge to target safety assessment and molecular and investigative toxicology projects and looks forward to contributing to the development of safe and effective medicines.

Peggy Guzzie-Peck

MS PhD DABT

Peggy has over 30 years’ experience working in various global scientific and management roles in nonclinical toxicology at large pharmaceutical companies (Pfizer, Johnson & Johnson and G.D. Searle).  Previous roles included Global Head, Toxicology, Pathology, Head of Preclinical Investigative Safety Sciences and Global Head, Genetic Toxicology.  Peggy graduated from the University of Pittsburgh and is now based in Florida.  Peggy is a long-standing diplomate of the American Board of Toxicology with a diverse background over all pharmaceutical therapeutic areas, predominantly specialising in small molecules and more recently in Cell/Gene therapies.

Susan Tantawi

DABT

Based in Montreal in Canada, Susan has over fifteen years’ experience working in CROs, consultancies and biotechnology companies.  With broad toxicology expertise, Susan also has specialist knowledge of inhalation toxicity. Always keen to support the progress of a compound to the next stage, she particularly enjoys the structured organisation involved in timelines and gap analysis.  Susan is a board certified toxicologist.

Jo Kilgour

PhD

Jo Kilgour is an expert Inhalation, having worked in the field for 30 years, initially working in the agrochemicals and chemicals sector at Central Toxicology Laboratory as a Study Director and Project Toxicologist, and for the last 20 years working almost exclusively in inhaled drug development, formerly at AstraZeneca.

Jo works with small and large Pharma companies worldwide to deliver toxicology programs for small molecules and biologics to support First in Human studies (Phase 1) through to Phase 3 clinical trials and registration. She has represented clients in interactions with Regulators in Europe and the US, and worked on drugs (small and large molecule) targeting many therapeutic areas including COPD, asthma, cystic fibrosis, idiopathic pulmonary fibrosis and anti-virals.

Jo has been an active member of the British Toxicology Society and the Association of Inhalation Toxicologists, Chairing the latter since 2011. She has co-authored a number of pivotal papers under the banner of the AIT and Industry Consortia, and has been an invited expert speaker at a number institutions and events including the US FDA, the European Chemicals Agency (EChA) and the University of Birmingham.

Charlotte Warrender

Charlotte worked at AstraZeneca for over ten years in a combined role of bench scientist and Facility Manager. She continued to work in a laboratory as a QC scientist, laboratory analyst and study investigator before becoming a dedicated Facility Manager ensuring equipment and facilities are kept to a high standard, looking after health and safety and ordering equipment.  A collaborative and knowledgeable individual, Charlotte constantly seeks to add value to the scientific setting.

Read more about Charlotte Warrender

Donna Martin

Donna spent 30 years at Alderley Park working first at Imperial Chemical Industries, then Zeneca then AstraZeneca.  Much of her career was spent in Human Resources, starting as a generalist, finally specialising in recruitment.  Donna is very at home with systems and lists and easily made the transition from recruitment to finance.

Read more about Donna Martin

Heather Brown

Heather graduated from the University of York with a BSc in Biology.  She enjoys data analysis and the representation of results and her final project dissertation was a review of in silico data and how it predicted laboratory findings.  Working on immunotoxicology capability development with Dr Sean Hammond, Heather is a conscientious and enthusiastic scientist, with a systematic approach to scientific issues.

Read more here Heather Brown

Leah Worthington

Leah graduated from the University of Birmingham with a degree in Biological Sciences.  Her interests are in ecology, genetics and disease.  Within the Target Safety Assessment team, she will be working on bioinformatics for TSAs, as well as gaining an overview of the whole process.  Leah’s broad biological knowledge and adaptability brings valuable capability and flexibility to the team

Read more here Leah Worthington

Haroon Rashid

PhD

Haroon has over 14 years of experience as a CRO study director, senior study director and toxicologist. He managed numerous investigative and regulatory toxicity studies for small molecules and biologicals in general and developmental and reproductive toxicology. He was involved in advising clients about their preclinical programmes, study design and execution, data interpretation and reporting for regulatory submission. Haroon brings his problem-solving skills and collaborative approach to the delivery of projects in an effective and timely manner.

Read more here Haroon Rashid